Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Metformin
29%
Type 2 Diabetes Risk
25%
Data Sharing
21%
Glucagon-like
21%
Glycaemic Deterioration
20%
Metabolic Traits
20%
Hemoglobin A1c (HbA1c)
19%
Post-load Glucose
17%
Innovative Medicines Initiative
17%
Glucose Curve
15%
Diabetes Research
12%
Patient Stratification
12%
Adiposity
12%
Insulin Resistance
12%
Glycemic Response
11%
Liver Fat
10%
Whole Blood
10%
Meta-analysis
10%
Subgroup 2
10%
Observational Data
10%
Oral Glucose Tolerance Test
9%
Genome-wide Association Study
9%
Abdominal MRI
8%
Ectopic Liver
8%
Gene Regulatory Network
8%
MRI Imaging
8%
Complex Traits
8%
Common Property
8%
GAD65 Autoantibodies
8%
Type 1 Diabetes Genetic Risk Score
8%
Molecular Phenotype
8%
Data Governance
8%
Genetic Analysis
8%
Views of Research
8%
Beta Cell Glucose Sensitivity
8%
Participant Views
8%
Metformin Therapy
8%
Deep Learning
8%
Gene Module
8%
Governance Structure
8%
Genome-wide Analysis
8%
Insulin Therapy
8%
Low Risk
8%
Newly Diagnosed
8%
Hypertension
8%
Genome-wide Association Analysis
8%
Motivation
8%
Randomized Controlled Trial
8%
Metabolic Biomarkers
8%
Follistatin
8%
Evidence-based
8%
Clinical Heterogeneity
8%
GLP-1 Receptor Agonist
8%
Multi-omics
8%
Etiological Heterogeneity
8%
Pancreatic β-cells
8%
Glycemic Traits
8%
Pharmacogenomics
8%
Metabolite Ratios
8%
Imaging Data
8%
Heart Disease
8%
Potential Biomarkers
8%
Data Access
8%
European Countries
8%
Metabolic Types
8%
Pharmacokinetics
8%
Omics
8%
Real-world Population
8%
Clinical Profile
8%
Cardiometabolic Disease
8%
Lifestyle Parameters
8%
Network Imputation
8%
Proteomic Network
8%
New-onset Type 2 Diabetes
7%
De-identified Data
6%
Data Access Committees
6%
Meal Tolerance Test
6%
Biomedical Research
6%
Diabetes
6%
Insulin Secretion
6%
Plasma Samples
6%
Multimodal Data
5%
Matsuda Index
5%
Gene Set
5%
Insulin
5%
GWAS Variants
5%
Gene Expression
5%
OGTT
5%
Single nucleotide Polymorphism
5%
Risk Factors
5%
Latent Class Trajectory Analysis
5%
Highest Peak
5%
Biochemistry, Genetics and Molecular Biology
Genome Wide Association Study
26%
Genetics
23%
Tamsulosin
20%
Genome-Wide Association Study
17%
Gene Expression
17%
Allele
17%
Receptor Agonists
17%
Glucagon-Like Peptide-1
17%
Glucagon-Like Peptide 1 Receptor
17%
Maturity Onset Diabetes of the Young
17%
Insulin Resistance
14%
Blood Plasma
13%
Pharmacokinetics
13%
Metabolite
11%
Magnetic Resonance Imaging
11%
Glucose Blood Level
11%
Insulin Release
10%
Triglyceride
9%
Pharmacogenomics
9%
Regulatory Network
8%
Genetic Risk
8%
Single-Nucleotide Polymorphism
8%
Randomized Controlled Trial
8%
Metabolomics
8%
Transporter Genes
8%
Glucose Tolerance Test
8%
Glucose Test
8%
Dyslipidemia
8%
Follistatin
8%
Transcriptomics
8%
Phenylalanine
8%
Proteomics
8%
Metabolic Network
8%
Unspecific Monooxygenase
8%
Genetic Regulation
7%
Candidate Gene
5%
Insulin
5%
GUSB
5%
Glycemia
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
82%
Diabetes
26%
Glycemic
25%
Glucagon Like Peptide 1
19%
Glucose Test
17%
Deterioration
17%
Biological Marker
11%
Fatty Liver
10%
Hemoglobin A1c
10%
Genetic Risk
10%
Glutamate Decarboxylase 65
8%
Follistatin
8%
Glycon
8%
Magnetic Resonance Imaging
8%
Allele
8%
Heart Disease
8%
Insulin Treatment
8%
Autoantibodies
8%
Metabolite
8%
Insulin Dependent Diabetes Mellitus
8%
Medicine
8%
Insulin Resistance
8%
Oral Glucose Tolerance Test
7%
Body Mass Index
5%